TEXs impaired T cell activity in a tumor microenvironment by reducing the expression of CD3 and JAK3 in primary activated T cells and by mediating Fas/FasL (Fas ligand)-driven CD8+ T cells death [23]. This evidence concerns the gene FASLG and neoplasm.